Search

Your search keyword '"Katada, Y."' showing total 328 results

Search Constraints

Start Over You searched for: Author "Katada, Y." Remove constraint Author: "Katada, Y."
328 results on '"Katada, Y."'

Search Results

1. Multicenter Analysis of Endovascular Aortic Arch In Situ Stent-Graft Fenestrations for Aortic Arch Pathologies

11. Coronary risk factors in Kowasaki disease treated with additional gammaglobulin

26. The difference in size between single pronuclei after ICSI and after IVF

30. THU0249 Early Therapeutic Intervention with Methotrexate (MTX) Prevents Development of Rheumatoid Arthritis (RA) in Patients with Undifferentiated Arthritis (UA), Even in the Presence of Smoking or the HLA-DR B1-Shared Epitope

31. AB0943 Monocyte/Neutrophil (M/N) CD64 Ratio is Useful for Differentiating Infection from Disease Activity in Systemic Lupus Erythematosus (SLE) Patients: Table 1.

33. SAT0074 Smoking Cessation Significantly Reduces Failure of BIOLOGICS (BIO)-Treatment in Rheumatoid Arthritis (RA): from the “Ninja” Registry Cohort of Japanese Patients

34. AB0449 Baseline Procalcitonin (PCT) Level as A Predictive Marker for Clinical Remission (DAS28-ESR, CDAI) at 52 Weeks in Biologic NaÏVe Rheumatoid Arthritis (RA) Patients Treated by TOCILIZUMAB (TCZ); A Single Center Retrospective Study

35. AB0940 The Prevalence of Achalasia among Patients with Autoimmune Diseases

36. FRI0079 Plasma Pentraxin3 (PTX3) as A Novel Useful Biomarker for Infection in Patients with Rheumatoid Arthritis (RA)

37. FRI0091 Neutrophil CD64 (NCD64) as A Useful Marker for Differentiating Organizing Pneumonia (OP) from Bacterial Pneumonia (BP) in Rheumatoid Arthritis (RA)

38. SAT0002 Quantitative CD64 Molecules on Peripheral Blood Monocytes in Systemic Lupus Erythematosus (SLE)

39. SAT0003 Quantitative Monocyte CD64 (MCD64) Expression is Useful Biomarker for Disease Activity in Systemic Lupus Erythematosus (SLE) Patients: Table 1.

40. Oxidation decomposition of cyanide ion using TiO2 and N-doped TiO2 photocatalysts.

42. THU0235 Prevention of Development of Rheumatoid Arthritis (RA) in Patients with Undifferentiated Arthritis (UA) by Very Early Therapeutic Intervention of Methotrexate (MTX)

43. SAT0079 The analysis of fecal microbiota in rheumatoid arthritis patients compared to healthy volunteers using bacterial RRNA-targeted reverse transcription-quantitative PCR

44. THU0442 Serum Prepsepsin (Soluble CD14-Subtype) as a Novel Useful Biomaker for Infection in Patients with Rheumatoid Arthritis (RA)

45. SAT0059 Association of Serum Antibody Responses to Porphyromonas Gingivalis and Periodontal Conditions with Clinical Response to Biologics in Rheumatoid Arthritis Patients

46. SAT0103 The analysis of reasons of discontinuing biologics in japanese patients with rheumatoid arthritis; from the ninja (national database of rheumatic disease by IR-net in japan)

47. SAT0144 The Causes of Discontinuation of Biologics(Bio)-Use in the Treatment of Rheumatoid Arthritis (RA) Under Practical Circumstances in Japan: from the “Ninja” Registry

48. SAT0135 Procalcitonin (PCT) Level as a Predictor Of Remission in Rheumatoid Arthritis (RA) Patients Receiving Tocilizumab (TCZ): A Single-Center Retrospective Study

49. SAT0415 Diagnostic and predictive value of novel method for analyzing IGG galactosylation in rheumatoid arthritis

50. OP0191 The Fecal Microbiota of Rheumatoid Arthritis Patients Differs from that of Healthy Volunteers and is Considerably Altered by Treatment with Biologics

Catalog

Books, media, physical & digital resources